
ABSTRACT Background Lip hyperpigmentation is an aesthetic concern. Evidence supporting light‐based treatments for diffuse lip hyperpigmentation is limited. This study evaluated the efficacy and safety of 755‐nm picosecond laser versus intense pulsed light (IPL) for the treatment of diffuse lip hyperpigmentation. Methods In this 12‐week, prospective, randomized, controlled, evaluator‐blinded trial, 50 patients were assigned 1:1 to five sessions of either a 755‐nm picosecond laser or IPL at 2‐week intervals. The primary endpoint was the Physician's Global Assessment (PGA) score at Week 12. Secondary endpoints included objective colorimetric parameters (CIE L *, a *, b *), Global Aesthetic Improvement Scale (GAIS), Dermatology Life Quality Index (DLQI), and pain Numerical Rating Scale (NRS). Treatment‐related adverse events were also recorded. Results Forty‐four patients completed the study (IPL, n = 20; picosecond laser, n = 24). Among completers, the median PGA score at Week 12 was higher in the picosecond laser group than in the IPL group (2.5 [IQR, 2–3] vs. 1.5 [IQR, 1–2.375]; p = 0.007; Hodges–Lehmann estimate, 0.5 PGA points; 95% CI, 0–1.0), and more patients achieved at least moderate improvement (79.2% vs. 45.0%). In sensitivity analyses, statistical significance depended on assumptions about missing PGA outcomes. Objective colorimetric changes did not differ significantly between groups (all p > 0.05). All completers reported improvement on the GAIS, and DLQI scores decreased in both groups. Pain NRS scores were higher in the picosecond laser group ( p < 0.01). Transient scaling occurred in 2 ps‐laser recipients; no adverse events were reported with IPL. Conclusion Both the 755‐nm picosecond laser and IPL showed improvement in diffuse lip hyperpigmentation, with favorable safety profiles. The picosecond laser showed greater physician‐assessed improvement among completers, whereas IPL was better tolerated. These findings may help guide individualized treatment selection. Trial Registration Chinese Clinical Trial Registry, ChiCTR2600116083
ABSTRACT Background The Alma Hybrid laser is a multi‐technology device that combines both ablative and non‐ablative lasers to target water and induce photo‐thermolysis for skin treatment, in a fractional manner. The combination of fractionation and sonophoresis enables a novel technological approach with the potential to significantly enhance the delivery and absorption of cosmeceuticals, such as phloretin, into and through the epidermis and into the dermis. Phloretin exhibits potent antioxidant properties that effectively neutralize free radicals and inhibit lipid peroxidation, helping to reduce inflammation and consequent facial discoloration. Aims To present practical insights on the safety of transepidermal delivery of Phloretin CF serum for hyperpigmentation. Methods Three case vignettes were selected to demonstrate the typical safety profile of this intervention. Results Pain and stinging at the end of the laser treatment were mostly mild or moderate in intensity; subsequent application of phloretin induced extra symptomatology that was transient and resolved immediately following sonophoresis. Improvement in hyperpigmentation was observed, as indicated by both VISIA absolute scores and VISIA feature counts, as well as patient‐reported improvement in radiancy. Conclusions This case series supports the safety and tolerability of delivering transepidermal Phloretin CF serum using fractional ablative CO 2 laser combined with sonophoresis, whilst allowing for deeper serum penetration.
ABSTRACT Background Unofficial use of skin lightening products (SLPs) for cosmetic purposes is a rising public health concern. In Tanzania, the challenges in regulating SLP retail outlets have allowed products containing harmful ingredients to remain accessible, posing particular risks to young women, including university students. Study Aim To determine the prevalence of skin lightening practices and associated factors among undergraduate female university students in the Kilimanjaro region, northern Tanzania. Methodology A cross‐sectional study was conducted from May 2024 to June 2024 among undergraduate female students from three universities in Moshi Urban District, Kilimanjaro region. Multistage stratified sampling, proportionate to size, was used to select 414 participants. Data were collected using an online, self‐administered, structured questionnaire via Kobo toolbox. Chi‐square test was used to determine significant differences in proportions across categories of the variables, and perceived colorism among SLP users and non‐users was analyzed using two‐tailed t ‐tests. Furthermore, multiple logistic regression was applied to determine factors associated with the use of SLPs. Results The prevalence of SLPs use among participants was 45.5% (95% CI: 40.8%–50.4%). Creams were the most commonly used form (52.1%), followed by the combined use of soaps and gels (23.4%). Composite colorism scores were significantly higher in SLP users than non‐users (17.54 vs. 13.87; p < 0.001). Factors independently associated with SLPs use were fair skin color (AOR = 2.1; 95% CI: 1.33–3.43; p = 0.002), white skin color (AOR = 1.99; 95% CI: 1.06–3.71; p = 0.031), and off‐campus residence (AOR = 1.7; 95% CI: 1.12–2.69; p = 0.014). Conclusion Nearly half of the undergraduate female students surveyed used SLPs, with a significant proportion using banned products containing harmful ingredients such as hydroquinone and corticosteroids, often in combination. These findings highlight the crucial need for stronger regulatory enforcement by the Tanzania Bureau of Standards, and for the studied universities to implement targeted educational programmes that promote skin health and behavior change among female students in order to promote evidence‐based, safer beauty choices among students.
ABSTRACT Background Micro‐Focused Ultrasound (MFU) is widely used for noninvasive facial rejuvenation. However, its effects on the middle and lower face have not been fully evaluated using multimodal assessment methods. Aims This study aimed to evaluate the efficacy and safety of a single MFU treatment for tightening and lifting of the middle and lower face by combining clinical evaluation with imaging‐based assessments. Methods Thirty female patients who underwent a single MFU treatment session were retrospectively included. Treatment was performed using both linear transducers (M3.0/M4.5) and large focal‐zone transducers (D3.0/D4.5). Clinical outcomes were evaluated using the Global Aesthetic Improvement Scale (GAIS), Facial Relaxation Scale (FRS), and Wrinkle Severity Rating Scale (WSRS) at baseline and at 1 and 3 months after treatment. Dermal thickness and echogenicity were assessed using high‐frequency ultrasound, and skin parameters were analyzed with the VISIA system. Pain scores and adverse events were also recorded. Results GAIS and FRS scores improved significantly at both follow‐up visits compared with baseline ( p < 0.001). Nasolabial fold severity was significantly reduced at 1 month ( p < 0.0167), with no further significant change observed at 3 months. High‐frequency ultrasound showed significant increases in dermal thickness and echogenicity after treatment ( p < 0.001). VISIA analysis demonstrated significant improvements in wrinkles, texture, pores, and brown spots ( p < 0.0167), whereas spots, redness, and UV pigmentation showed no significant changes. Pain was mild in 70% of patients. All adverse events were mild and transient. Conclusions A single MFU treatment can improve mid‐to‐lower facial laxity and overall facial appearance. Given the study limitations, this conclusion should be considered preliminary and exploratory in nature.
ABSTRACT Background Retinoids are widely used in the treatment of wrinkles and photoaging. However, they frequently cause irritation and increase sun sensitivity. As a result, there has been greater emphasis for the evaluation of alternative ingredients and naturally derived ingredients. Almond oil, rich in unsaturated fatty acids and antioxidant vitamin E, has been used traditionally for facial care and anti‐aging regimens. However, there have not been any comparative studies on the use of topical tretinoin on its impact on facial wrinkles. Aims To evaluate the effects of topical almond oil (with and without vitamin E) versus tretinoin 0.025% on the appearance of facial wrinkles and photoaging. Patients/Methods In a 16‐week randomized, double‐blind trial, 79 participants were assigned to daily facial application of either almond oil, almond oil + 0.5% vitamin E, or tretinoin 0.025%. Image‐based quantification of wrinkles, skin hydration, and pigmentation was assessed at baseline and Weeks 4, 8, 12, and 16. Results By Week 16, all groups achieved a significant reduction in the appearance of wrinkle severity ( p < 0.001) with no between‐group differences. The almond oil + vitamin E group provided no additional wrinkle benefit over almond oil alone. Melanin levels significantly increased in the almond oil group at week 16 (4%, p = 1.8E‐6), whereas the almond oil + vitamin E group showed no significant increases. Conclusions Topical almond oil produced wrinkle severity improvements comparable to tretinoin 0.025% by 16 weeks, supporting its use as a natural alternative to retinoids for anti‐aging. Adding vitamin E with almond oil demonstrated no significant wrinkle benefit but may help attenuate the slight pigmentation increase observed with almond oil alone. Almond oil alone appeared to naturally increase the appearance of skin pigmentation that may warrant further study in other clinical settings.